2020
18 Adverse kidney effects of immunotherapies
SALY D, PERAZELLA M. 18 Adverse kidney effects of immunotherapies. 2020, 166-182.e3. DOI: 10.1016/b978-0-323-54945-5.00027-8.Peer-Reviewed Original ResearchKidney diseaseDrug-induced kidney diseaseHigh-dose interleukin-2B-cell acute lymphoblastic leukemiaChimeric antigen receptor T cellsAntigen receptor T cellsAdverse kidney effectsImmune checkpoint inhibitorsChronic kidney diseaseChronic kidney injuryNumber of medicationsReceptor T cellsAcute lymphoblastic leukemiaConventional chemotherapeutic drugsAcid-base disturbancesOlder immunotherapiesCheckpoint inhibitorsKidney injuryNovel immunotherapiesNew immunotherapiesCancer patientsKidney effectsKidney lesionsLymphoblastic leukemiaImmune cells
2009
Renal Vulnerability to Drug Toxicity
Perazella MA. Renal Vulnerability to Drug Toxicity. Clinical Journal Of The American Society Of Nephrology 2009, 4: 1275-1283. PMID: 19520747, DOI: 10.2215/cjn.02050309.Peer-Reviewed Original ResearchConceptsDrug-induced kidney diseaseKidney diseaseRenal vulnerabilityRisk factorsAcute kidney injuryChronic kidney diseaseDrug-related factorsProteinuric renal diseaseKidney injuryRenal complicationsRenal injuryRenal diseaseNephrotoxic effectsRenal syndromeDrug toxicityDiseaseInjuryKidneyDrugsFactor categoriesToxinComplicationsPatientsFactorsTubulopathy